Advertisement

The potential role of CD25+CD4+ regulatory T cells in the induction and maintenance of transplantation tolerance in humans

  • Kathryn J. Wood
  • Ahmed Akl
Chapter
Part of the Progress in Inflammation Research book series (PIR)

Keywords

Regulatory Cell Transplantation Tolerance Allograft Tolerance Cardiac Allograft Survival Donor Alloantigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Gershon R, Kondo K (1971) Infectious immunlogical tolerance. Immunology 21: 903–914PubMedGoogle Scholar
  2. 2.
    Kilshaw P, Brent L, Pinto M (1975) Suppressor T cells in mice made unresponsive to skin allografts. Nature 255: 489–491PubMedGoogle Scholar
  3. 3.
    Wood KJ, Sakaguchi S (2003) Regulatory T cells in transplantation tolerance. Nat Immunol Rev 3: 199–210Google Scholar
  4. 4.
    Lechler, R, Garden OA, Turka L (2003) The complementary roles of deletion and regulation in transplantation tolerance. Nat Rev Immunol 3: 147–158PubMedGoogle Scholar
  5. 5.
    Hutchinson IV (1986) Suppressor T cells in allogeneic models. Transplantation 41: 547–555PubMedGoogle Scholar
  6. 6.
    Gilliet M, Liu Y-J (2002) Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J Exp Med 195(6): 695–704PubMedGoogle Scholar
  7. 7.
    Zhou J, Carr RI, Liwski RS, Stadnyk AW, Lee GTD (2001) Oral exposure to alloantigen generates intragraft CD8+ regulatory cells. J Immunol 167: 107–113PubMedGoogle Scholar
  8. 8.
    Ciubotariu R, Colovai AI, Pennesi G, Liu Z, Smith D, Berlocco P, Cortesini R, Suciu-Foca N (1998) Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28-regulatory T cells. J Immunol 161: 5193–5202PubMedGoogle Scholar
  9. 9.
    Zhang Z, Yang L, Young K, DuTemple B, Zhang L (2000) Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 6: 782–789PubMedGoogle Scholar
  10. 10.
    Zeng D, Lewis D, Dejbakhsh-Jones S, Lan F, Garcia-Ojeda M, Sibley R, Strober S (1999) Bone marrow NK1.1− and NK 1.1+ T cells reciprocally regulate acute graft-versus-host disease. Blood 99: 1449–1457Google Scholar
  11. 11.
    Seino K-I, Fukao K, Muramoto K, Yanagisawa K, Takada Y, Kakuta S, Iwakura Y, Van Kaer L, Takeda K, Nakayama T et al (2001) Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci 98: 2577–2581PubMedGoogle Scholar
  12. 12.
    Taylor P, Noelle RJ, Blazar BR (2001) CD4+CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193: 1311–1318PubMedGoogle Scholar
  13. 13.
    Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S (2002) Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-Versus-host disease after allogeneic bone marrow transplantation. J Exp Med 196: 389–399PubMedGoogle Scholar
  14. 14.
    Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL (2002) CD4+CD25+ Immunoregulatory T cells: new therapeutics for graft-Versus-host disease. J Exp Med 196: 401–406PubMedGoogle Scholar
  15. 15.
    Hall B, Pearce N, Gurley K, Dorsch S (1990) Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterisation of the CD4+ suppressor cell and its mechanisms of action. J Exp Med 171: 141–157PubMedGoogle Scholar
  16. 16.
    Pearce N, Berger M, Gurley K, Spinelli A, Hall B (1993) Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine: vi. in vitro alloreactivity of T cell subsets from rats with long-surviving allografts. Transplantation 55: 380–389PubMedGoogle Scholar
  17. 17.
    Hara M, Kingsley C, Niimi M, Read S, Turvey S, Bushell A, Morris P, Powrie F, Wood KJ (2001) IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166: 3789–3796PubMedGoogle Scholar
  18. 18.
    Kingsley CI, Karim M, Bushell AR, Wood KJ (2002) CD25+CD4+ Regulatory T cells prevent graft rejection: CTLA-4 and IL-10-dependent immunoregulation of allore-sponses. J Immunol 168: 1080–1086PubMedGoogle Scholar
  19. 19.
    Sanchez-Fueyo A, Weber M, Domenig C, Strom T, Zheng X (2002) Tracking immunoregulatory mechanisms during allograft tolerance. J Immunol 168: 2274–2281PubMedGoogle Scholar
  20. 20.
    Graca L, Thompson S, Lin C-Y, Adams E, Cobbold SP, Waldmann H (2002) Both CD4+CD25+ and CD4+CD25 regulatory cells mediate dominant transplantation tolerance. J Immunol 168: 5558–5565PubMedGoogle Scholar
  21. 21.
    Lehmann M, Graser E, Risch K, Hancock W, Muller A, Kuttler B, Hahn H, Kupiec-Weglinski J, Brock J, Volk H (1997) Anti-CD4 monoclonal antibody-induced allograft tolerance in rats despite persistence of donor-reactive T cells. Transplantation 64: 1181–1187PubMedGoogle Scholar
  22. 22.
    Baecher-Allan C, Brown J, Freeman G, Hafler D (2001) CD4+CD25+ high regulatory cells in human peripheral blood. J Immunol 167: 1245–1253PubMedGoogle Scholar
  23. 23.
    Levings M, Sangregorio R, Roncarolo M-G (2001) Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193: 1295–1301PubMedGoogle Scholar
  24. 24.
    Jonuleit H, Stassen EM, Tuettenberg A, Knop J, Enk A (2001) Identification and functional characterisation of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J Exp Med 139: 1285–1294Google Scholar
  25. 25.
    Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI (2001) Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood 98: 2736–2744PubMedGoogle Scholar
  26. 26.
    Stephens L, Mottet C, Mason D, Powrie F (2001) Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Fur J Immunol 31: 1247–1254Google Scholar
  27. 27.
    Taams L, Smith J, Rustin M, Salmon M, Poulter L, Akbar A (2001) Human anergic/suppresor CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Fur J Immunol 31: 1122–1131Google Scholar
  28. 28.
    Meloni F, Vitulo P, Bianco AM, Paschetto E, Morosini M, Cascina A, Mazzucchelli I, Ciardelli L, Oggionni T, Fietta AM et al (2004) Regulatory CD4+CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 77: 762–766PubMedGoogle Scholar
  29. 29.
    Li Y, Koshiba T, Yoshizawa A, Yonekawa Y, Masuda K, Ito A, Ueda M, Mori T, Kawamoto H, Tanaka Y et al (2004) Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transpl 4: 2118–2125Google Scholar
  30. 30.
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self tolerance maintained by activated T cells expressing IL-2 receptor alpha chains (CD25) Breakdown of a single mechanism of self tolerance causes various autoimmune diseases. J Immunol 155: 1151–1164PubMedGoogle Scholar
  31. 31.
    Kuniyasu Y, Takahashi T, Itoh M, Shimizu J, Toda G, Sakaguchi S (2000) Naturally anergic and suppressive CD25+CD4+ T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol 12: 1145–1155PubMedGoogle Scholar
  32. 32.
    Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G (2001) Ex vivo isolation and characterisation of CD4+CD25+ T cells with regulatory properties from human blood. J Exp Med 139: 1303–1310Google Scholar
  33. 33.
    Zelenika D, Adams E, Humm S, Graca L, Thompson S, Cobbold SP, Waldmann H (2002) Regulatory T cells overexpress a subset of Th2 gene transpcripts. J Immunol 168: 1069–1079PubMedGoogle Scholar
  34. 34.
    Wood KJ, Ushigome H, Karim M, Bushell A, Hori S, Sakaguchi S (2003) Regulatory cells in transplantation. Novartis Foundation Symp 252: 177–188Google Scholar
  35. 35.
    Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S (2002) Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self tolerance. Nat Immunol 3: 135–142PubMedGoogle Scholar
  36. 36.
    McHugh RS, Whitters M, Piccirillo C, Young D, Shevach EM, Collins M, Byrne M (2002) CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311–323Google Scholar
  37. 37.
    Nocentini G, Giunchi L, Ronchetti S, Krausz LT, Bartoli A, Moraca R, Migliorati G, Riccardi C (1997) A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci 94: 6216–6221PubMedGoogle Scholar
  38. 38.
    Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by transcription factor FOXP3. Science 299: 1507–1061Google Scholar
  39. 39.
    Fontenot J, Gavin M, Rudensky A (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330–336PubMedGoogle Scholar
  40. 40.
    Khattri R, Cox T, Yasayko S, Ramsdell F (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4: 304–306PubMedGoogle Scholar
  41. 41.
    Stassen M, Schmitt E, Jonuleit H (2004) Human CD(4+)CD(25+) regulatory T cells and infectious tolerance. Transplantation 77: S23–S25PubMedGoogle Scholar
  42. 42.
    Bennett CL, Christie F, Ramsdell F, Brunkow PJ, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001) The immune dysregulation, polyen-docrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27: 20–21PubMedGoogle Scholar
  43. 43.
    Herold K, Hagopian W, Auger J, Poumian-Ruiz E, Taylor L, Donaldson D, Gitelman S, Harlan D, Xu D, Zivin R et al (2002) Anti-CD3 monoclonal antibody in new onset type 1 diabetes mellitus. N Engl J Med 346: 1740–1742PubMedGoogle Scholar
  44. 44.
    Spitzer T, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, Colby C, Sykes M, Sachs D, Cosimi A (1999) Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohe-matopoietic chimersim. Transplantation 68: 480–484PubMedGoogle Scholar
  45. 45.
    Fandrich F, Zhou X, Schlemminger M, Lin X, Dresske B (2002) Future strategies for tolerance induction: a comparative study between hematopoietic stem cells adn macrophages. Hum Immunol 63: 805–812PubMedGoogle Scholar
  46. 46.
    Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T (2001) Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumour immunity and transplantation tolerance. Immunol Rev 182: 18–32PubMedGoogle Scholar
  47. 47.
    Maloy K, Powrie F (2001) Regulatory T cells in the control of immune pathology. Nat Immunol Rev 2: 816–822Google Scholar
  48. 48.
    Kawahata K, Misaki Y, Yamauchi M, Tsunekawa S, Setoguchi K, Miyazaki J, Yamamoto K (2002) Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J Immunol 168: 4399–4405PubMedGoogle Scholar
  49. 49.
    Sakaguchi S, Hori S, Fukui Y, Sasazuki T, Sakaguchi N, Takahashi T (2003) Thymic generation and selection of CD25+CD4+ regulatory T cells: Implications of their broad repertoire and high self-reactivity for the maintenance of immunologic self-tolerance. Novartis Foundation Symp 252: 6–16Google Scholar
  50. 50.
    Taams L, Vukmanovic-Stejic M, Smith J, Dunne P, Fletcher J, Plunkett F, Ebeling S, G Lombardi, Rustin M, Bijlsma J et al (2002) Antigen specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur Immunol 32: 1621–1630Google Scholar
  51. 51.
    Hsieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, Rudensky AY (2004) Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 2: 267–277Google Scholar
  52. 52.
    Lechler RI, Lombardi G, Batchelor JR, Reinsmoen N, Bach FH (1990) The molecular basis of alloreactivity. Immunol Today 11: 83–88PubMedGoogle Scholar
  53. 53.
    Graca L, Le Moine A, Lin C-Y, Fairchild PJ, Cobbold SP, Waldmann H (2004) Donor-specific transplantation tolerance: The paradoxical behavior of CD4+CD25+ T cells. Proc Natl Acad Sci 101: 10122–10126PubMedGoogle Scholar
  54. 54.
    Karim M, Kingsley CI, Bushell A, Sawitzki B, Wood KJ (2004) Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25–CD4+ precursors in a thymus independent process. J Immunol 172: 923–928PubMedGoogle Scholar
  55. 55.
    Nishimura E, Sakihama T, Setoguchi R, Tanaka K, Sakaguchi S (2004) Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Int Immunol 16: 1189–1202PubMedGoogle Scholar
  56. 56.
    Karim M, Bushell A, Wood KJ (2002) Regulatory T cells in transplantation. Curr Opin Immunol 14: 584–591PubMedGoogle Scholar
  57. 57.
    Taams L, Vukmanovic-Stejic M, Salama AD, Akbar A (2003) Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance. Transpl Immunol 11: 277–285PubMedGoogle Scholar
  58. 58.
    Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM (2002) CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor {beta}l production and responsiveness. J Exp Med 196: 237–246PubMedGoogle Scholar
  59. 59.
    van Maurik A, Wood KJ, Jones N (2002) Cutting edge: CD4(+)CD25(+) alloantigen-specific immunoregulatory cells that can prevent CD8(+) T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol 169: 5401–5404PubMedGoogle Scholar
  60. 60.
    Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G (2002) Human CD4+CD25+ regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells. J Exp Med 196: 247–253PubMedGoogle Scholar
  61. 61.
    Camara N, Sebille F, Lechler R (2003) Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation. Eur J Immunol 33: 3473–3483PubMedGoogle Scholar
  62. 62.
    Thornton A, Shevach E (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal activation by inhibiting interleukin 2 production. J Exp Med 188: 287–296PubMedGoogle Scholar
  63. 63.
    Frasca L, Scotta C, Lombardi G, Piccolella E (2002) Human anergic CD4+ T cells can act as suppressor cells by affecting autologous dendritic cell conditioning and survival. J Immunol 168: 1060–1068PubMedGoogle Scholar
  64. 64.
    Thornton A, Shevach EM (2000) Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen non-specific. J Immunol 164: 183–190PubMedGoogle Scholar
  65. 65.
    Josien R, Douillard P, Guillot C, Muschen M, Anegon I, Chetritt J, Menoret S, Vigens C, Soulillou J, Cuturi M (1998) A critical role for transforming growth factor beta in donor transfusion induced allograft tolerance. J Clin Invest 102: 1920–1926PubMedGoogle Scholar
  66. 66.
    Cobbold SP, Castejon R, Adams E, Zelenika D, Graca L, Humm S, Waldmann H (2004) Induction of foxP3+ regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J Immunol 172: 6003–6010PubMedGoogle Scholar
  67. 67.
    Chen W, Wahl SM (2003) TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression. Cytokine Growth Factor Rev 2: 85–89Google Scholar
  68. 68.
    Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz D (2002) Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25 precursors. J Immunol 169: 4183–4189PubMedGoogle Scholar
  69. 69.
    Cederbom L, Hall H, Ivars F (2000) CD4+CD25+ regulatory T cells down-regulate costimulatory molecules on antigen presenting cells. Eur J Immunol 30: 1538–1543PubMedGoogle Scholar
  70. 70.
    Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, Waldmann H (1993) “Infectious” transplantation tolerance. Science 259: 974–977PubMedGoogle Scholar
  71. 71.
    Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH (2002) Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells. J Exp Med 196(2): 255–260PubMedGoogle Scholar
  72. 72.
    Onodera K, Hancock WW, Graser E, Lehmann M, Sayegh MH, Strom TB, Volk HD, Kupiec-Weglinski JW (1997) Type 2 helper T cell-type cytokines and the development of “infectious” tolerance in rat cardiac allograft recipients. J Immunol 158: 1572–1581PubMedGoogle Scholar
  73. 73.
    Waterhouse P, Penninger J, Timms E, Wakeham A, Shahinian A, Lee K, Thompson C, Griesser H, Mak T (1995) Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270: 985–988PubMedGoogle Scholar
  74. 74.
    Takahashi T, Tagami T, Yamazaki S, Uede T, Shimuzu J, Sakaguchi N, Mak T, Sakaguchi S (2000) Immunologic self tolerance is maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte associated antigen 4. J Exp Med 192: 303–310PubMedGoogle Scholar
  75. 75.
    Read S, Malmstrom V, Powrie F (2000) Cytotoxic T lymphocyte associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 192: 295–302PubMedGoogle Scholar
  76. 76.
    Manzotti CN, Tipping H, Perry LC, Mead KI, Blair PJ, Zheng Y, Sansom DM (2002) Inhibition of human T cell proliferation by CTLA-4 utilizes CD80 and requires CD25+ regulatory T cells. Eur J Immunol 32(10): 2888–2896PubMedGoogle Scholar
  77. 77.
    Perez V, van Parjis L, Biuckians A, Zheng X, Strom T, Abbas A (1997) Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6: 411–417PubMedGoogle Scholar
  78. 78.
    Baecher-Allan C, Brown J, Freeman G, Hafler D (2003) CD4+CD25+ regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. Novartis Foundation Symp 252: 67–88Google Scholar
  79. 79.
    Yamagiwa S, Gray J, Hashimoto S, Horwitz D (2001) A role of TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood. J Immunol 166: 7282–7289PubMedGoogle Scholar
  80. 80.
    Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O’Garra A (2002) In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Thl)-and Th2-inducing cytokines. J Exp Med 195: 603–616PubMedGoogle Scholar
  81. 81.
    Taylor A, Namba K (2001) In vitro induction of CD25+CD4+ regulatory T cells by the neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH). Immunol Cell Biol 79: 358–367PubMedGoogle Scholar
  82. 82.
    Taylor PA, Lees CJ, Blazar BR (2002) The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99: 3493–3499PubMedGoogle Scholar
  83. 83.
    Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M (2004) Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104: 895–903PubMedGoogle Scholar
  84. 84.
    Iellern A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D’Ambrosio D (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J Exp Med 194: 847–854PubMedGoogle Scholar
  85. 85.
    Bystry R, Aluvihare V, Welch K, Kallikourdis M, Betz A (2001) B cells and professional APCs recruit regulatory T cells. Nat Immunol 2: 1126–1132PubMedGoogle Scholar
  86. 86.
    Herbelin A, Gombert J, Lepault F, Bach J, Chatenoud L (1998) Mature mainstream TCR alpha beta+ CD4+ thymocytes expressing L-selectin mediate “active tolerance” in the nonobese diabetic mouse. J Immunol 161: 2620–2628PubMedGoogle Scholar
  87. 87.
    Chatenoud L, Salomon B, Bluestone J (2001) Suppressor T cells — they’re back and critical for regulation of autoimmunity. Immunol Rev 182: 149–163PubMedGoogle Scholar
  88. 88.
    Stassen M, Fondel S, Bopp T, Richter C, Muller C, Kubach J, Becker C, Knop J, Enk AH, Schmitt S et al (2004) Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. J Immunol 34: 1303–1311PubMedGoogle Scholar
  89. 89.
    Konieczny B, Dai Z, Elwood E, Saleem S, Linsley P, Baddoura F, Larsen C, Pearson T, Lakkis F (1998) IFN-γ is critical for long-term allograft survival indcued by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 160: 2059–2064PubMedGoogle Scholar
  90. 90.
    Furtado GC, de Lafaille MAC, Kutchukhidze N, Lafaille JJ (2002) Interleukin 2 signaling is required for CD4+ regulatory T cell function. J Exp Med 196: 851–857PubMedGoogle Scholar
  91. 91.
    Larsen P, Elwood E, Alexander D, Ritchie S, Hendrix R, Tucker-Burden C, Cho H, Aruffo A, Hollenbaugh D, Insley PL et al (1996) Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381: 434–438PubMedGoogle Scholar
  92. 92.
    Kirk A, Burkly L, Batty D, Baumgartner R, Berning J, Buchanan K, Fechner J, Germond R, Kampen R, Patterson N et al (1999) Treatment with humanised monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 5: 686–693PubMedGoogle Scholar
  93. 93.
    Opelz G (1995) Efficacy of rejection prophylaxis with OKT3 in renal transplantation. Collaborative Transplant Study. Transplantation 60: 1220–1224PubMedGoogle Scholar
  94. 94.
    Takatsuki M, Uemoto S, Inomata Y, Egawa H, Kiuchi T, Fujita S, Hayashi M, Kanematsu T, Tanaka K (2001) Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 72: 449–454PubMedGoogle Scholar
  95. 95.
    Kupiec-Weglinski JW, Filho M, Strom T, Tilney N (1984) Sparing of suppressor cells: A critical action of cyclosporine. Transplantation 38: 97–101PubMedGoogle Scholar
  96. 96.
    Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L (2001) Regulatory T cells induced by 1{alpha},25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 167: 1945–1953PubMedGoogle Scholar
  97. 97.
    Vincenti F (2001) Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens. Transpl Proc 33: 3169–3171Google Scholar
  98. 98.
    Jones TR, Ha J, Williams MA, Adams AB, Durham MM, Rees PA, Cowan SR, Pearson TC, Larsen CP (2002) The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts. J Immunol 168: 1123–1130PubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2005

Authors and Affiliations

  • Kathryn J. Wood
    • 1
  • Ahmed Akl
    • 1
  1. 1.Nuffield Department of SurgeryUniversity of Oxford, John Radcliffe HospitalOxfordUK

Personalised recommendations